What is the feasibility and utility of home monitoring in ILD?

The potential role of home monitoring in ILD has been amplified by the COVID-19 pandemic.

A systematic review by Althobiani, MA et al. (2021) evaluated the evidence for the use of home monitoring for early detection of exacerbations and/or progression of ILD. The review reports that home monitoring “is feasible and of potential benefit in patients with ILD”. Studies have also reported that mean adherence to home monitoring was >75%, and where spirometry was performed there was a “significant correlation between home and hospital-based readings”.

[vital_featured_image]

The review concludes that while individual studies “provide supportive evidence suggesting the feasibility and utility of home monitoring in ILD, further studies are necessary to quantify the potential of home monitoring to detect disease progression and/or AEs.”

Clinical Trials

Clinical Trial Services

Our clinical trial services are designed to add value to your specific study needs and to contribute to the operational design of your study. 

Data
Project
Clinical
Training
Software
eCOA
Support

Talk to our team